Moorfields Eye Hospital NHS FT
London, EC1V 2PD, United Kingdom
NCT Number: NCT02822612
Ophthalmology is among the most technology driven of all medical specialties, with advanced medical imaging devices - and specialised computer software - increasingly adopted for routine clinical use. While many such devices are capable of completing specific tasks, lack of "usability" prevents their widespread adoption (i.e., such devices are not easy to learn and remember, or are not efficient or subjectively pleasing to use). Moreover, devices that are difficult to use expose patients to clinical risk as a result of human error during usage.
With the introduction of a new medical technology, it is essential, therefore, to have a deep understanding of patients, what they need, what they value, their abilities, and also their limitations.
Human factor and usability testing, also known as "human factor engineering", deals with the formal study of people's interaction with their environment (in this case, the binocular optical coherence tomography (OCT) device). Structured, patient-centred, usability testing is essential to the design, clinical validation, regulatory approval, and widespread implementation, of all new medical devices. This is particularly the case for a putative binocular OCT system - a device intended for automated use in visually impaired, often elderly, populations. Although the binocular OCT is already at an advanced stage of hardware development, the EASE study will facilitate an iterative process of operating software and workflow modifications to optimize the device for use in these populations.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
London, EC1V 2PD, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for participants with chronic eye disease will include:
Exclusion criteria
for participants with chronic eye disease will include:
Inclusion criteria
for healthy subjects will include:
Exclusion criteria
for healthy subjects will include:
Testing will begin using a prototype binocular OCT system. Subjects will undergo the full suite of diagnostic assessments offered by the system at that time (i.e., visual acuity, ophthalmic history, pupillometry, ocular motility, perimetry, anterior segment and posterior segment OCT imaging).
Time frame: 6 months
Total time for each participant to complete the binocular optical coherence tomography (OCT) examination was calculated.
Time frame: 6 months
Participants rated ease of use, duration, and appeal on a 5-point Likert scale in a post-test questionnaire.
Time frame: 4 months
To identify potential user errors, particularly those with a likelihood of generating erroneous examination findings (e.g., failure to comply with device instructions or errors in voice recognition).
University College, London
Other
A Prospective Single-Site Non-Interventional Study to Evaluate Human Factors and Usability of Automated, Comprehensive Ocular Examination in Elderly and Visually Impaired Populations Using a Prototype Binocular Optical Coherence Tomography System
Acronym: EASE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03076697
Age Related Macular Degeneration, Cardiovascular Diseases
View Trial DetailsNCT06496763
Cornea, Corneal Diseases
Taipei County, Taiwan
View Trial DetailsNCT04318132
Corneal Disease, Corneal Diseases
Andover, Massachusetts, United States
View Trial DetailsNCT00792259
Eye Diseases, Glaucoma
Bronxville, New York, United States
View Trial Details